Hexavest’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-657
Closed -$57K 466
2019
Q3
$57K Hold
657
﹤0.01% 329
2019
Q2
$60K Sell
657
-76
-10% -$6.43K ﹤0.01% 330
2019
Q1
$63K Hold
733
﹤0.01% 317
2018
Q4
$56K Hold
733
﹤0.01% 291
2018
Q3
$57K Hold
733
﹤0.01% 337
2018
Q2
$50K Hold
733
﹤0.01% 344
2018
Q1
$53K Hold
733
﹤0.01% 373
2017
Q4
$55K Hold
733
﹤0.01% 391
2017
Q3
$56K Hold
733
﹤0.01% 390
2017
Q2
$55K Hold
733
﹤0.01% 388
2017
Q1
$49K Hold
733
﹤0.01% 392
2016
Q4
$48K Hold
733
﹤0.01% 393
2016
Q3
$52K Hold
733
﹤0.01% 394
2016
Q2
$54K Hold
733
﹤0.01% 401
2016
Q1
$48K Hold
733
﹤0.01% 393
2015
Q4
$57K Hold
733
﹤0.01% 381
2015
Q3
$60K Hold
733
﹤0.01% 372
2015
Q2
$65K Hold
733
﹤0.01% 377
2015
Q1
$65K Hold
733
﹤0.01% 365
2014
Q4
$61K Hold
733
﹤0.01% 368
2014
Q3
$62K Hold
733
﹤0.01% 370
2014
Q2
$59K Hold
733
﹤0.01% 365
2014
Q1
$56K Hold
733
﹤0.01% 364
2013
Q4
$53K Hold
733
﹤0.01% 311
2013
Q3
$50K Hold
733
﹤0.01% 320
2013
Q2
$46K Buy
+733
New +$47.7K ﹤0.01% 323

Other funds holding NVS

Hexavest's NVS Position: Q4 2019 in Review

Hexavest sold out of Novartis (NVS) in Q4 2019, closing a stake of 657 shares — an estimated $57K sold.

Hexavest first reported a position in NVS in Q2 2013 and held it in 26 quarters. The position peaked at $65K in Q2 2015. 1,173 funds tracked by Wall St. Rank hold NVS as of Q4 2019.

  • Hexavest reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
  • Hexavest sold 657 Novartis shares in Q4 2019, an estimated $57K.
  • Hexavest first reported a position in Novartis in Q2 2013 and held it in 26 quarters.
  • Hexavest's Novartis position peaked at $65K in Q2 2015.
  • 1,173 funds tracked by Wall St. Rank held Novartis as of Q4 2019.

Based on Hexavest's 13F filing for Q4 2019, filed 9 Jan 2020.